Christopher Metzger

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

Gunnar Tepe, John R. Laird, Peter A. Schneider et al. · Circulation · 2014 · 667 citations · Full text

Medicine, Surgery, Interventional Cardiology +15

Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions

John R. Laird, Peter A. Schneider, Gunnar Tepe et al. · Journal of the American College of Cardiology · 2015 · 370 citations · Full text

Medicine, Surgery, Drug Repurposing +15

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds

Dean J. Kereiakes, Stephen G. Ellis, Christopher Metzger et al. · Journal of the American College of Cardiology · 2017 · 264 citations

Medicine, Biomedical Engineering, Cardiology +14

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries

Peter A. Schneider, John R. Laird, Gunnar Tepe et al. · Circulation Cardiovascular Interventions · 2018 · 218 citations · Full text

Medicine, Cardiology, Surgery +16

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease

Prakash Krishnan, Peter L. Faries, Khusrow Niazi et al. · Circulation · 2017 · 214 citations · Full text

Medicine, Pharmacotherapy, Surgery +17